Clough Capital Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,110
Closed -$8.31M 124
2025
Q1
$8.31M Buy
+19,110
New +$8.31M 1.04% 39
2024
Q4
Sell
-32,284
Closed -$16.8M 133
2024
Q3
$16.8M Buy
32,284
+6,375
+25% +$3.32M 1.72% 18
2024
Q2
$14M Buy
25,909
+2,595
+11% +$1.41M 1.53% 19
2024
Q1
$12.1M Buy
23,314
+19,115
+455% +$9.91M 1.33% 31
2023
Q4
$1.98M Sell
4,199
-801
-16% -$378K 0.22% 77
2023
Q3
$2.18M Hold
5,000
0.23% 89
2023
Q2
$2.22M Hold
5,000
0.22% 110
2023
Q1
$2.3M Hold
5,000
0.25% 102
2022
Q4
$2.56M Buy
+5,000
New +$2.56M 0.26% 83
2021
Q3
Sell
-33,725
Closed -$12.9M 122
2021
Q2
$12.9M Sell
33,725
-41,250
-55% -$15.7M 0.7% 55
2021
Q1
$26.9M Buy
+74,975
New +$26.9M 1.2% 17
2019
Q2
Sell
-66,458
Closed -$19.1M 116
2019
Q1
$19.1M Buy
66,458
+30,735
+86% +$8.82M 1.67% 19
2018
Q4
$9.38M Buy
+35,723
New +$9.38M 1.1% 28
2015
Q2
Sell
-44,780
Closed -$6.91M 209
2015
Q1
$6.91M Sell
44,780
-48,700
-52% -$7.52M 0.23% 119
2014
Q4
$11.7M Buy
93,480
+45,550
+95% +$5.72M 0.42% 88
2014
Q3
$5.73M Sell
47,930
-148,200
-76% -$17.7M 0.21% 111
2014
Q2
$21.1M Sell
196,130
-113,670
-37% -$12.2M 0.67% 60
2014
Q1
$30.8M Buy
309,800
+52,500
+20% +$5.23M 0.96% 34
2013
Q4
$23.8M Sell
257,300
-34,400
-12% -$3.18M 0.78% 46
2013
Q3
$24.4M Buy
291,700
+88,800
+44% +$7.42M 0.76% 45
2013
Q2
$16.6M Buy
+202,900
New +$16.6M 0.55% 63